Melt Pharmaceuticals (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 02, 2024
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $24,000,000
Company Info
- Founders
- Dr. Larry Dillaha
- Company Description
- Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.
- Market
- Clinical-stage therapeutics for sedation and analgesia
- Location
- Brentwood, Tennessee, United States